Idera Pharmaceuticals, Inc.
IDRA
Market Cap$26.5M
Close$
Share Statistics
| Market cap | $26.50 Million |
|---|---|
| Enterprise Value | $-2,477,941.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.67 |
| Beta | 0.66 |
| Outstanding Shares | 62,355,434 |
| Avg 30 Day Volume | 325,737 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | -0.36 |
| Price to Sales | -0.43 |
| Price to Book Ratio | -0.43 |
| Enterprise Value to Revenue | 5.01 |
| Enterprise Value to EBIT | 0.06 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Idera Pharmaceuticals, Inc.
CEO: Vincent Milano